Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Objectives: To investigate the treatment effect between insulin,metformin and Liraglutide; in
Type 2 Diabetes in our hospital, in order to investigate the possible mechanism about
telomere-telomerase system and Par-4.